FDA publishes discussion paper on regulating generative AI-enabled medical devices
The FDA's Center for Devices and Radiological Health (CDRH) issued a discussion paper on 18 August 2026 on regulatory considerations for medical devices that use generative AI, and is seeking public feedback. The FDA's digital health chief says regulatory guidance on generative AI is in preparation.
Who is affected and how
- medtech company
- Companies should comment on the paper, because the planned guidance will set the authorization pathway for generative AI products.
- health IT
- Teams developing or procuring software with generative functions should anticipate future FDA expectations.
- health policy
- The public consultation offers a model for regulating fast-changing generative AI within device law.
- doctor
- The status and evidence base of generative tools used on the client side may become clearer as a result of the regulation.
Sources
- FDA Introduces a Potential Review Architecture for Generative AI-Enabled Medical Deviceswilson sonsini · Aug 24, 2026
- FDA prepares guidance on medical devices with generative AI — STAT Newsua.news · Aug 24, 2026
- FDA Introduces a Potential Review Architecture for Generative AI-Enabled Medical Devices | Wilson Sonsiniwsgr.com · Aug 24, 2026
- FDA Is Preparing New Rules for Generative AI Medical Devicestoolhunt.io · Aug 24, 2026
- FDA Opens Comment Process for Generative-AI Medical Devicesfindarticles.com · Aug 25, 2026
- FDA Requests Feedback on Considerations for Generative AI-Enabled Medical Devices Regulationoffice of advocacy (.gov) · Aug 26, 2026
- FDA Evaluation of AI-Enabled Medical Devices | QCCqualitycommercialconsultants.com · Aug 26, 2026
- FDA AI Medical Devices: What Authorization Provespolicyedgeai-intelligence-terminal.ghost.io · Aug 27, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.